Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
Authors
Keywords
-
Journal
BMC Complementary and Alternative Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-06
DOI
10.1186/s12906-019-2728-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low serum creatinine predicts risk for type 2 diabetes
- (2018) Xue Bao et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway
- (2018) Xiao Lei et al. LIFE SCIENCES
- Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage
- (2018) Yifeng Zheng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway
- (2018) Bin Leng et al. LIFE SCIENCES
- Diabetic retinopathy, metabolic memory and epigenetic modifications
- (2017) Renu A. Kowluru VISION RESEARCH
- Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury
- (2017) Selim Fakhruddin et al. Journal of Diabetes Research
- Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network
- (2017) Xinhui Liu et al. PLoS One
- Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy
- (2016) Hengjiang Guo et al. Frontiers in Pharmacology
- SIRT1 protects against myocardial ischemia–reperfusion injury via activating eNOS in diabetic rats
- (2015) Mingge Ding et al. Cardiovascular Diabetology
- Effects of Astragaloside IV on diabetic nephropathy in rats
- (2015) W.-S. Lu et al. GENETICS AND MOLECULAR RESEARCH
- Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
- (2015) Zeng Si Wang et al. BMC Nephrology
- Down-Regulation of PERK-ATF4-CHOP Pathway by Astragaloside IV is Associated with the Inhibition of Endoplasmic Reticulum Stress-Induced Podocyte Apoptosis in Diabetic Rats
- (2014) Yifang Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
- (2014) Jianguo Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro
- (2014) Li Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF-κB pathway under high glucose conditions
- (2014) LI SUN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Vascular Endothelial Growth Factor-Receptor 1 Inhibition Aggravates Diabetic Nephropathy through eNOS Signaling Pathway in db/db Mice
- (2014) Keun Suk Yang et al. PLoS One
- Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats
- (2014) Yonghui Yin et al. BioScience Trends
- Role of Endothelial Nitric Oxide Synthase in Diabetic Nephropathy: Lessons from Diabetic eNOS Knockout Mice
- (2014) Takamune Takahashi et al. Journal of Diabetes Research
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression
- (2013) Dingkun Gui et al. CYTOKINE
- Aberrant Activation of the Intrarenal Renin-Angiotensin System in the Developing Kidneys of Type 2 Diabetic Rats
- (2013) Y.-Y. Fan et al. HORMONE AND METABOLIC RESEARCH
- Astragaloside IV Stimulates Angiogenesis and Increases Nitric Oxide Accumulation via JAK2/STAT3 and ERK1/2 Pathway
- (2013) Shi-Guang Wang et al. MOLECULES
- Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice
- (2012) Huifang Cheng et al. KIDNEY INTERNATIONAL
- Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
- (2012) Dingkun Gui et al. PLoS One
- Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism
- (2011) Andrew Advani et al. AMERICAN JOURNAL OF PATHOLOGY
- Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
- (2009) Jian Xu et al. CIRCULATION
- Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy
- (2008) R. Komers et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started